Gartner
IT NYSE IT Consulting & Other Services Financials FY2016βFY2025
Gartner's revenue rose 3.7% to $6.5 billion in fiscal 2025. Its operating margin was 15.8%, down from 18.4% a year earlier. Free cash flow was $1.2 billion, down 15.0%. It paid out $2.0 billion in dividends and buybacks, 169% of free cash flow. The diluted share count fell 3.5%.
What Gartner does
No business description yet.
- Legal name
- Gartner, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000749251-26-000112
0000749251
Revenue and margins
Gartner had $6.5B of revenue in fiscal 2025, up 3.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 17.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.2B in fiscal 2025, 18.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Gartner returned $2.0B to shareholders in fiscal 2025, 169% of free cash flow. The diluted share count fell 3.5%.
Value Gartner yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.3B and divides by 75.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 20.8x Β· peers 20.8x Β· sector 33.5x.
Balance sheet
Cash, debt and the ratios that show how comfortably Gartner can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $757M | $698M | $1.3B | $1.9B | $1.7B |
| Debt incl. finance leases | $2.5B | $2.5B | $2.5B | $2.5B | $3.0B |
| Net debt / EBITDA | 1.5x | 1.4x | 0.8x | 0.4x | 1.0x |
| Debt / equity | 6.6x | β | 3.6x | 1.8x | β |
| Interest coverage | 7.7x | 8.7x | 9.3x | 8.8x | 8.2x |
| Current ratio | 0.8x | 0.8x | 0.9x | 1.1x | 1.0x |
| Quick ratio | 0.8x | 0.8x | 0.9x | 1.1x | 1.0x |
| Total assets | $7.4B | $7.3B | $7.8B | $8.5B | $8.1B |
| Total liabilities | $7.0B | $7.1B | $7.2B | $7.2B | $7.8B |
| Shareholders' equity | $371M | $228M | $681M | $1.4B | $320M |
| Net debt (β = net cash) | $1.7B | $1.8B | $1.1B | $527M | $1.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$9.9M
2 insiders
Sold, 12 months
$1.5M
6 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Robin B KranichEVP & CHRO | Sold | 3,278 | $196.50 | $0.6M | Form 4 |
| Aug 24, 2026 | Akhil JainEVP, Consulting | Sold | 700 | $201.73 | $0.1M | Form 4 |
| Aug 10, 2026 | Yvonne GenoveseEVP, Bus. & Tech. Insights | Sold | 1,205 | $190.06 | $0.2M | Form 4 |
| Aug 7, 2026 | Anne Sutherland FuchsDirector | Sold | 860 | $184.30 | $0.2M | Form 4 |
| Aug 7, 2026 | Claire HerkesEVP, Conferences | Sold | 1,039 | $190.71 | $0.2M | Form 4 |
| Feb 5, 2026 | John J RinelloSVP, Global Business Sales | Bought | 50 | $154.13 | $0.0M | Form 4 |
| Dec 10, 2025 | Stephen G PagliucaDirector | Bought | 43,300 | $229.57 | $9.9M | Form 4 |
| Dec 3, 2025 | Claire HerkesEVP, Conferences | Sold | 367 | $231.56 | $0.1M | Form 4 |
| Dec 3, 2025 | John J RinelloSVP, Global Business Sales | Sold | 220 | $229.57 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 7 / 9 | 5 / 9 |
| Accruals ratio | β3.6% | β2.8% | β6.8% |
| Altman Z'' | 2.84 | 3.57 | 3.60 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Gartner IT | $15.3B | 3.7% | 15.8% | 18.1% | 44.6% | 20.8x | 5 | |
| DXC Technology DXC | $2.7B | β1.8% | 7.7% | 8.2% | 9.2% | 21.2x | 7 | Compare β |
| Kyndryl KD | $3.3B | 0.2% | β | 2.3% | 7.8% | 39.9x | 6 | Compare β |
| NCR Voyix VYX | $1.2B | β4.7% | 1.0% | β14.0% | 1.3% | 20.5x | 3 | Compare β |
| Cognizant CTSH | $33.6B | 7.0% | 16.1% | 12.3% | 16.2% | 15.3x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.4B | $3.3B | $4.0B | $4.2B | $4.1B | $4.7B | $5.5B | $5.9B | $6.3B | $6.5B |
| Gross profit | $1.5B | $2.0B | $2.5B | $2.7B | $2.8B | $3.3B | $3.8B | $4.0B | $4.3B | $4.5B |
| Operating income | $305M | β$6.3M | $260M | $370M | $490M | $916M | $1.1B | $1.2B | $1.2B | $1.0B |
| Interest expense | $27.6M | $128M | $127M | $103M | $116M | $119M | $126M | $133M | $131M | $125M |
| Pretax income | $288M | β$128M | $181M | $276M | $326M | $970M | $1.0B | $1.1B | $1.4B | $968M |
| Income tax | $94.8M | β$131M | $58.7M | $42.4M | $59.4M | $176M | $219M | $265M | $134M | $239M |
| Net income | $194M | $3.3M | $123M | $233M | $267M | $794M | $808M | $883M | $1.3B | $729M |
| Diluted EPS | $2.31 | $0.04 | $1.33 | $2.56 | $2.96 | $9.21 | $9.96 | $11.08 | $16.00 | $9.65 |
| Diluted shares | 0.08B | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.08B | 0.08B | 0.08B | 0.08B |
| Cash flow | ||||||||||
| Cash from operations | $366M | $255M | $471M | $565M | $903M | $1.3B | $1.1B | $1.2B | $1.5B | $1.3B |
| Capital expenditure | $49.9M | $111M | $127M | $149M | $83.9M | $59.8M | $108M | $103M | $102M | $115M |
| Free cash flow | $316M | $144M | $344M | $416M | $819M | $1.3B | $993M | $1.1B | $1.4B | $1.2B |
| Depreciation and amortization | $62.0M | $240M | $256M | $212M | $219M | $212M | $192M | $191M | $202M | $200M |
| Stock-based compensation | $46.7M | $78.9M | $66.2M | $69.0M | $62.5M | $98.6M | $90.6M | $130M | $155M | $156M |
| Acquisitions | $48.2M | $2.6B | $15.9M | $26.0M | $0.0M | $22.9M | $9.5M | $3.8M | $2.0M | $0.0M |
| Share buybacks | $59.0M | $41.3M | $261M | $199M | $176M | $1.7B | $1.0B | $606M | $735M | $2.0B |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $59.0M | $41.3M | $261M | $199M | $176M | $1.7B | $1.0B | $606M | $735M | $2.0B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $474M | $539M | $156M | $281M | $713M | $757M | $698M | $1.3B | $1.9B | $1.7B |
| Total debt | $694M | $3.3B | $2.3B | $2.2B | $2.0B | $2.5B | $2.5B | $2.5B | $2.5B | $3.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $1.3B | $2.6B | $1.8B | $2.0B | $2.3B | $2.6B | $2.8B | $3.4B | $4.2B | $4.1B |
| Current liabilities | $1.5B | $2.8B | $2.6B | $2.9B | $2.9B | $3.4B | $3.6B | $3.8B | $4.0B | $4.1B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $122M | $222M | $268M | $345M | $337M | $274M | $265M | $263M | $243M | $214M |
| Total assets | $2.4B | $7.3B | $6.2B | $7.2B | $7.3B | $7.4B | $7.3B | $7.8B | $8.5B | $8.1B |
| Total liabilities | $2.3B | $6.3B | $5.4B | $6.2B | $6.2B | $7.0B | $7.1B | $7.2B | $7.2B | $7.8B |
| Shareholders' equity | $60.9M | $984M | $851M | $939M | $1.1B | $371M | $228M | $681M | $1.4B | $320M |
| Margins | ||||||||||
| Gross margin | 61.3% | 60.1% | 63.1% | 63.5% | 67.2% | 69.5% | 69.7% | 68.3% | 68.3% | 68.8% |
| Operating margin | 12.5% | β0.2% | 6.5% | 8.7% | 12.0% | 19.3% | 20.1% | 20.9% | 18.5% | 15.8% |
| EBITDA margin | 15.0% | 7.1% | 13.0% | 13.7% | 17.3% | 23.8% | 23.6% | 24.2% | 21.7% | 18.9% |
| Net margin | 7.9% | 0.1% | 3.1% | 5.5% | 6.5% | 16.8% | 14.8% | 14.9% | 20.0% | 11.2% |
| FCF margin | 12.9% | 4.3% | 8.7% | 9.8% | 20.0% | 26.5% | 18.1% | 17.8% | 22.1% | 18.1% |
| Returns | ||||||||||
| Return on capital | 68.9% | β0.3% | 5.2% | 10.8% | 15.4% | 33.8% | 42.5% | 49.9% | 56.4% | 44.6% |
| Return on capital employed | 34.8% | β0.2% | 6.5% | 9.4% | 11.3% | 21.8% | 28.4% | 31.9% | 26.8% | 23.9% |
| Return on equity | β | 0.6% | 13.4% | 26.1% | 26.3% | 108.6% | β | 194.3% | 122.9% | 86.9% |
| Return on assets | 8.5% | 0.1% | 1.8% | 3.5% | 3.7% | 10.8% | 11.0% | 11.7% | 15.3% | 8.8% |
| Growth | ||||||||||
| Revenue growth | 13.0% | 35.5% | 20.1% | 6.8% | β3.4% | 15.5% | 15.7% | 7.9% | 6.1% | 3.7% |
| Net income growth | 10.2% | β98.3% | 3,634.6% | 90.5% | 14.3% | 197.5% | 1.8% | 9.2% | 42.1% | β41.8% |
| EPS growth | 12.1% | β98.3% | 3,225.0% | 92.5% | 15.6% | 211.2% | 8.1% | 11.2% | 44.4% | β39.7% |
| FCF growth | 5.5% | β54.5% | 139.5% | 21.0% | 96.8% | 52.9% | β20.7% | 6.0% | 31.4% | β15.0% |
| Share count change | β1.5% | 7.1% | 2.6% | β1.3% | β1.1% | β4.3% | β5.9% | β1.7% | β1.7% | β3.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.6x | 11.7x | 4.1x | 3.3x | 1.8x | 1.5x | 1.4x | 0.8x | 0.4x | 1.0x |
| Debt / equity | β | 3.3x | 2.7x | 2.3x | 1.8x | 6.6x | β | 3.6x | 1.8x | β |
| Interest coverage | 11.1x | β0.1x | 2.1x | 3.6x | 4.2x | 7.7x | 8.7x | 9.3x | 8.8x | 8.2x |
| Current ratio | 0.9x | 0.9x | 0.7x | 0.7x | 0.8x | 0.8x | 0.8x | 0.9x | 1.1x | 1.0x |
| Quick ratio | 0.9x | 0.9x | 0.7x | 0.7x | 0.8x | 0.8x | 0.8x | 0.9x | 1.1x | 1.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.0% | 3.3% | 3.2% | 3.5% | 2.1% | 1.3% | 2.0% | 1.8% | 1.6% | 1.8% |
| Stock comp / revenue | 1.9% | 2.4% | 1.7% | 1.6% | 1.5% | 2.1% | 1.7% | 2.2% | 2.5% | 2.4% |
| Payouts / FCF | 18.7% | 28.7% | 75.8% | 47.8% | 21.5% | 132.2% | 105.1% | 57.6% | 53.2% | 169.4% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 4.0 | 6.0 | 9.0 | 7.0 | 7.0 | 7.0 | 8.0 | 7.0 | 5.0 |
| Altman Z'' | 2.8 | 0.7 | 0.5 | 0.6 | 1.1 | 1.6 | 2.0 | 2.8 | 3.6 | 3.6 |
| Accruals ratio | β7.6% | β5.2% | β5.2% | β5.0% | β8.8% | β7.0% | β4.0% | β3.6% | β2.8% | β6.8% |
Source: SEC EDGAR XBRL filings (CIK 0000749251). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.